Cargando…
ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
BACKGROUND: A-disintegrin and metalloproteinases (ADAMs) are members of a family of multidomain transmembrane and secreted proteins. Specific ADAMs are upregulated in human cancers and correlated with tumor progression and poor outcome, but rarely studied in human hilar cholangiocarcinoma (HC). This...
Autores principales: | Jiao, Xiaodong, Yu, Wenlong, Qian, Jianxin, Chen, Ying, Wei, Peilian, Fang, Wenzheng, Yu, Guanzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960197/ https://www.ncbi.nlm.nih.gov/pubmed/29776401 http://dx.doi.org/10.1186/s12885-018-4294-9 |
Ejemplares similares
-
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
por: Chen, Ying, et al.
Publicado: (2015) -
PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma
por: Yu, Guanzhen, et al.
Publicado: (2015) -
Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021) -
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018) -
FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
por: Zhang, Chunli, et al.
Publicado: (2018)